Open report — full analysis, no account required.

Sign up to generate reports and read filings that aren't on the open list.

Sign up free

Get notified when RYAN files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts
NYSE: RYAN RYAN SPECIALTY HOLDINGS, INC. 8-K

Ryan Specialty reports 7.2% Q2 revenue growth, returns $284.5M to shareholders

Filed July 30, 2026 · Period ending July 30, 2026 · ~1 min read

4 key changes 3 high relevance 1 section

Key Changes

  • high

    Q2 revenue grew 7.2% to $916.6M with 6.7% organic growth driven by new clients, strong retention, and specialty market flow; Adjusted EBITDAC up 6.0% to $326.9M but margin compressed 40bp to 35.7%

    Exhibit 99.1 view on EDGAR →
  • high

    Returned $284.5M to shareholders in Q2: $260.0M in share repurchases (8.1M shares) and $24.5M in dividends; $300.0M repurchase authorization remains

    Exhibit 99.1 view on EDGAR →
  • medium

    Board declared $0.13 per share quarterly dividend on Class A common stock, payable August 25, 2026 to shareholders of record August 11, 2026

    Item 8.01 — Other Events verify on EDGAR →
  • high

    Maintained full-year 2026 organic revenue growth guidance at mid-single digits; updated Adjusted EBITDAC margin guidance to down 50-100bp versus 2025

    Exhibit 99.1 view on EDGAR →

Summary

Ryan Specialty reported solid Q2 2026 results with 7.2% revenue growth to $916.6 million, driven by 6.7% organic growth across most casualty lines. The company's specialty and E&S market positioning continues to generate new client wins and strong renewal retention.

However, profitability metrics show margin pressure: Adjusted EBITDAC grew 6.0% but the margin compressed 40 basis points to 35.7%, reflecting higher compensation and general/administrative expenses outpacing revenue growth. The company updated full-year margin guidance to down 50-100 basis points versus 2025, signaling this trend may persist. Capital allocation remains aggressive.

Ryan Specialty returned $284.5 million to shareholders in Q2 through $260.0 million in share repurchases (8.1 million shares) and $24.5 million in dividends, with $300.0 million of repurchase authorization remaining. The board declared a $0.13 per share quarterly dividend payable August 25, 2026. The combination of sustained organic growth and substantial capital return demonstrates management's confidence in cash generation, though investors should monitor whether margin compression stabilizes or accelerates through the second half of 2026.

Section-by-Section Diff

Event · Exhibit 99.1

1 Added
Added Q2 2026 profitability metrics high

Added in current filing · view on EDGAR → · paraphrased

Adjusted EBITDAC* grew 6.0% year-over-year to $326.9 million ... Adjusted EBITDAC Margin* of 35.7%, compared to 36.1% in the prior-year period ... Adjusted Diluted Earnings Per Share grew 12.1% or $0.74 per diluted share

Adjusted EBITDAC increased 6.0% to $326.9 million, though the margin compressed 40 basis points to 35.7% from 36.1% in the prior year. Adjusted Diluted EPS grew 12.1% to $0.74, outpacing revenue and EBITDAC growth due to share repurchases reducing the share count. Net income decreased 13.1% to $108.4 million, primarily due to higher operating expenses and income tax expense.

Was this report useful?

Figures/quotes linked to EDGAR · Narrative written by AI · Jul 31, 2026 · How we verify